France
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 8.69 B
|
Dec. 31, 2023 | USD 107.71 | -0.06% |
|
France |
|
2 |
USD 81.97 M
|
Dec. 31, 2023 | USD 76.53 | 1.34% |
|
France |
|
3 |
USD 11.19 M
|
Dec. 31, 2023 | USD 26.53 | 0.03% |
|
France |
|
4 |
USD 2.28 M
|
Dec. 31, 2023 | USD 3.46 | -1.94% |
|
France |
|
5 |
USD -7.13 M
|
Dec. 31, 2023 | USD 2.39 | -7.42% |
|
France |
|
6 |
USD -7.90 M
|
Dec. 31, 2023 | USD 1.42 | 2.06% |
|
France |
|
7 |
USD -13.98 M
|
Dec. 31, 2023 | USD 2.09 | 3.97% |
|
France |
|
8 |
USD -14.82 M
|
Dec. 31, 2023 | USD 1.64 | -0.17% |
|
France |
|
9 |
USD -19.45 M
|
Dec. 31, 2023 | USD 5.82 | 3.14% |
|
France |
|
10 |
USD -22.63 M
|
March 31, 2024 | USD 17.01 | 1.06% |
|
France |
|
11 |
USD -25.37 M
|
Dec. 31, 2023 | USD 6.79 | 2.49% |
|
France |
|
12 |
USD -29.56 M
|
Dec. 31, 2023 | USD 3.58 | 3.12% |
|
France |
|
13 |
USD -37.55 M
|
Dec. 31, 2023 | USD 0.63 | -3.60% |
|
France |
|
14 |
USD -76.43 M
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
15 |
USD -90.60 M
|
Dec. 31, 2023 | USD 3.46 | 7.58% |
|
France |
|
16 |
USD -113.37 M
|
Dec. 31, 2023 | USD 2.40 | -1.45% |
|
France |
|
17 |
USD -140.59 M
|
Dec. 31, 2023 | USD 6.04 | 2.29% |
|
France |
The Vaccines company in France with the highest Operating Income is Sanofi (Paris Stock Exchange: SAN.PA) at USD 8.69 B.
The Vaccines company in France with the lowest Operating Income is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at USD -140.59 M.
The top 10 Vaccines companies in France by Operating Income are Sanofi, Vetoquinol SA, Eurobio Scientific SA, genOway SA, Aelis Farma SA, Valbiotis SA, Innate Pharma S.A., AB Science S.A., Adocia SA and MedinCell S.A..
The bottom 10 Vaccines companies in France by Operating Income are ABIVAX SA, Inventiva S.A., Valneva SE, DBV Technologies S.A., Novacyt S.A., Nanobiotix S.A., OSE Immunotherapeutics SA, MedinCell S.A., Adocia SA and AB Science S.A..